Intravenous Immunoglobulins Market to Reach US$ 15,789.1 Mn by 2025, Exhibiting A CAGR of 6.2% | Fortune Business Insights


You May Also Like

Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors

CAMBRIDGE, Mass., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical ...

ContraFect Corporation Prices $10 Million Public Offering of Common Stock

YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company ...